HTLV-I infection: Virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals

Iranian Journal of Allergy, Asthma and Immunology

Volumn 5, Issue 4, 2006, Pages 153-166

  Rafatpanah, Houshang ^a   Farid, Reza ^a   Golanbar, Gelareh ^a   Azad, Farahzad Jabbari ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CTL response; Cytokine gene polymorphism; HAM TSP; HTLV I; MHC

Indexed keywords

TAX PROTEIN;

CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HELPER CELL; HLA SYSTEM; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENETICS; IRAN; NONHUMAN; REVIEW; RISK FACTOR; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TH1 CELL; TH2 CELL; VIRUS MORPHOLOGY; VIRUS TRANSMISSION;

DELTARETROVIRUS INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS;

EID: 33845473260     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Koralnik I. Structure of HTLV-I. In: Hollsberg P, Hafler D, editors. Human T-cell lymphotropic virus type I. New York: John Wiley and Sons Ltd, 1996: 65-78.
2. Brady JN. Biology of HTLV-I: host cell interaction. In: Hollsberg P. Hafler DA, editors. Human T cell lymphotropic virus type I. London: John Wiley and Sons, 1996: 79-12.
3. Seiki M, Hattori MS, Hirayama MY, Yoshida MM. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A 1983; 80(12):3618-22.
4. Green MP, Chen MI. Molecular features of the human T-cell leukaemia virus: mechanism of transformation and leukemogenicity. In: Levy A, editor. The Retroviridae. New York: Plenium Press, 1994: 277-311.
5. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985; 229(4714):675-9.
6. Rosen C, Sodroski JG, Haseltine WA. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat. Proc Natl Acad Sci U S A 1985; 82(19):6502-6.
7. Shimotohno K, Takano M, Teruuchi T, Miwa M. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for transacting activation of transcription. Proc Natl Acad Sci U S A 1986; 83(21):8112-6.
8. Brady J, Jeang KT, Duvall J, Khoury G. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J Virol 1987; 61(7):2175-81.
9. Montminiy MR, Sevarino KA, Wagner JA. Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc Natl Acad Sci U S A 1986; 83(18):6682-6.
10. Hattori S, Kiyokawa T, Imagawa K, Shimizu F, Hashimura E, Seiki M, et al. Identification of gag and env gene products of human T-cell leukemia virus (HTLV). Virology 1984; 136(2):338-47.
11. Oroszlan S, Copeland TD. Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK. Curr Top Microbiol Immunol 1985; 115:221-33.
12. Green MP, Chen I. Molecular features of the human T-cell leukaemia virus: mechanism of transformation and leukemogenicity. In: Levy A, editor. The Retroviridae. New York: Plenium Press, 1994: 277-311.
13. Hunter E, Swanstrom R. Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol 1990; 157:187-253.
14. Delamarre L, Rosenberg AR, Pique C, Pham D, Callebaut I, Dokhelar MC. The HTLV-I envelope glycoproteins: structure and functions. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(Suppl 1):S85-S91.
15. Slamon DJ, Shimotohno K, Cline MJ, Golde DW, Chen IS. Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science 1984; 226(4670):61-5.
16. Lee TH, Coligan JE, Sodroski JG, Haseltine WA, Salahuddin SZ, Wong-Staal F, et al. Antigens encoded by the 3'-terminal region of human T-cell leukaemia virus: evidence for a functional gene. Science 1984; 226(4670):57-61.
17. Sodroski J, Rosen C, Goh WC, Haseltine W. A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. Science 1985; 228(4706):1430-4.
18. Sodroski JG, Rosen CA, Haseltine WA. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 1984; 225(4660):381-5.
19. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985; 229(4714):675-9.
20. Fujisawa J, Seiki M, Kiyokawa T, Yoshida M. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc Natl Acad Sci U S A 1985; 82(8):2277-81
21. Jeang KT. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B. Cytokine Growth Factor Rev 2001; 12(2-3):207-17.
22. Khorana AA, Rosenblatt JD, Young FM. Immunopathogenesis of HIV and HTLV-1 infection: mechanisms for lymphomagenesis. Cancer Treat Res 2001; 104:19-74.
23. Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Matsuoka M. Oncogene 2003; 22(33):5131-40.
24. Uchiyama T. Human T cell leukaemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997; 15:15-37.
25. Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci U S A 1998; 95(5):2452-7.
26. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood 1996; 88(3):1035-45.
27. Hiscott J, Petropoulos L, Lacoste J. Molecular interactions between HTLV-1 Tax protein and the NF-kappa B/kappa B transcription complex. Virology 1995; 214(1):3-11.
28. Jeang KT, Widen SG, Semmes OJ, Wilson SH. HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science 1990; 247(4946):1082-4.
29. Kiyokawa T, Seiki M, Iwashita S, Imagawa K, Shimizu F, Yoshida M. p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A 1985; 82(24):8359-63.
30. Hidaka M, Inoue J, Yoshida M, Seiki M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J 1988; 7(2):519-23.
31. Derse T, Mikovits J, Ruscetti F. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 1997; 237(1):123-8.
32. Robek MD, Wong FH, Ratner L. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol 1998; 72(5):4458-62.
33. Bartoe JT, Albrecht B, Collins ND, Robek MD, Ratner L, Green PL, et al. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol 2000; 74(3):1904-100.
34. Johnson JM, Harrod R, Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int J Exp Patho 2001; 82(3):135-47.
35. De The G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses 1993; 9(5):381-6.
36. Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide seroepidemiologic study. Int J Cancer 1982; 29(6):631-5.
37. Gessain A. Epidemiology of HTLV-I and associated diseases. In: Hollsberg P, Hafler DA, editors. Human T-cell lymphotroic virus type i. London: John Wiley and Sons, 1996: 33-64.
38. Blattner WA, Gallo RC. Epidemiology of HTLV-I and hTLV-II infection. In: Takatusuki K, editor. Adult T-cell leukemia. UK: Oxford University Press, 1994: 45-90.
39. Muller N. The epidemilogy of HTLV-I infection. Cancer Cases Control 1991; 2:37-52.
40. Kaplan JE, Khabbaz RF. The epidemilogy of humna T-lymphotropic viruse types I and II. Med Virol 1993; 3:137-148.
41. Levine PH, Blattner WA, Clark J, Tarone R, Maloney EM, Murphy EM, et al. Geographical distribution of HTLV-I and identification of a new high-risk population . Int J Cancer 1988; 42(1):7-12.
42. Safai B, Huang JL, Boeri E, Farid R, Raafat J, Schutzer P, et al. Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res Hum Retroviruses 1996; 12(12):1185-90.
43. Murphy EL, Fridey J, Smith JW, Engstrom J, Sacher RA, Miller K, et al. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology 1997; 48(2):315-20.
44. Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The Tand B-cell Malignancy Study Group. Int J Cancer 1990; 45(2):237-43.
45. Mochizuki M, Tajima K, Watanabe T, Yamaguchi K.. Human T lymphotropic virus type 1 uveitis. Br J Ophthalmol 1994; 78(2):149-54.
46. Biggar RJ, Johnson BK, Oster C, Sarin PS, Ocheng D, Tukei P, et al. Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa. Int J Cancer 1985; 35(6):763-7.
47. Wiktor SZ, Piot P, Mann JM, Nzilambi N, Francis H, Vercauteren G, et al. Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. J Infect Dis 1990; 161(6):1073-7.
48. Kondo T, Kono H, Miyamoto N, Yoshida R, Toki H, Matsumoto I, et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer 1989; 43(6):1061-4.
49. Maloney EM, Ramirez H, Levin A, Blattner WA. A survey of the human T-cell lymphotropic virus type I (HTLV-I) in south-western Colombia. Int J Cancer 1989; 44(3):419-23.
50. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 354(9187):1386.
51. Blattner WA, Blayney DW, Robert-Guroff M, Sarngadharan MG, Kalyanaraman VS, Sarin PS, et al. Epidemiology of human T-cell leukaemia/lymphoma virus. J Infect Dis 1983; 147(3):406-16.
52. Sidi Y, Meytes D, Shohat B, Fenig E, Weisbort Y, Lee H, et al. Adult T-cell lymphoma in Israeli patients of Iranian origin. Cancer 1990; 65(3):590-3.
53. Meytes D, Schochat B, Lee H, Nadel G, Sidi Y, Cerney M, et al Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group. Lancet 1990; 336(8730):1533-5.
54. Achiron A, Pinhas-Hamiel O, Doll L, Djaldetti R, Chen A, Ziv I, et al. Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews. Ann Neurol 1993; 34(5):670-5.
55. Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol 2003; 41:2593-5.
56. Tsuji Y, Doi H, Yamabe T, Ishimaru T, Miyamoto T, Hino S. Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics 1990; 86(1):11-7.
57. Hirata M, Hayashi J, Noguchi A, Nakashima K, Kajiyama W, Kashiwagi S, et al. The effects of breastfeeding and presence of antibody to p40tax protein of human T cell lymphotropic virus type-I on mother to child transmission. Int J Epidemiol. 1992; 21(5):989-94.
58. Komuro A, Hayami M, Fujii H, Miyahara S, Hirayama M. Vertical transmission of adult T-cell leukaemia virus. Lancet 1983; 1(8318):240.
59. Katamine S, Moriuchi R, Yamamoto T, Terada K, Eguchi K, Tsuji Y, et al. HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet 1994; 343(8909):1326-7.
60. Stuver SO, Tachibana N, Okayama A, Shioiri S, Tsunetoshi Y, Tsuda K, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993; 167(1):57-65.
61. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, Okochi K. Intrafamilial transmission of adult T cell leukaemia virus. J Infect Dis 1986; 154:851-7.
62. Bartholomew C, Saxinger WC, Clark JW, Gail M, Dudgeon A, Mahabir B, et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA 1987; 257:2604-8.
63. Gotoh YI, Sugamura K, Hinuma Y. Healthy carriers of a human retrovirus, adult T-cell leukemia virus (ATLV): demonstration by clonal culture of ATLV-carrying T cells from peripheral blood. Proc Natl Acad Sci U S A 1982; 79(15):4780-2.
64. Sato H, Okochi K. Transmission of ATLV (HTLV-I) through blood transfusion. Uirusu 1986; 36(2):195-201.
65. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992; 51(6):886-91.
66. Schwebke J, Calsyn D, Shriver K, Saxon A, Kleyn J, Oluoch-Mitchell E, et al. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users. J Infect Dis 1994; 169(5):962-7.
67. Hollsberg P, Hafler DA. Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection.N Engl J Med 1993: 328(16):1173-82.
68. Bangham CR. HTLV-I infection. J Clin Pathol 2000; 53(8):581-6.
69. Manns A, Murphy EL, Wilks R, Haynes G, Figueroa JP, Hanchard B, et al. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood 1991;77(4):896-905.
70. Nagasato K, Nakamura T, Shirabe S, Shibayama K, Ohishi K, Ichinose K, et al. Presence of serum antihuman T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I- associated myelopathy. J Neurol Sci 1991; 103(2):203-8.
71. Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, et al. I. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. J Neurol Sci 1992; 107(1):98-104.
72. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003; 299(5613):1713-6.
73. Bangham CR. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol 2003; 84(Pt 12):3177-89.
74. Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP, et al. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 2002; 99(9):3335-41.
75. Oh U, Grant C, Griffith C, Fugo K, Takenouchi N, Jacobson S. Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection.J Infect Dis 2006; 193(11):1557-66.
76. Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, et al. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 1991; 3(8):761-7.
77. Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, et al. Target epitope in the Tax protein of human T-cell leukaemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol 1992; 66:2928-33.
78. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease Nature 1990; 348(6298):245-8.
79. Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE. Immunological studies in tropical spastic paraparesis. Ann Neurol 1990; 27(2):149-56.
80. Jacobson S, Reuben JS, Streilein RD, Palker TJ. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1. J Immunol 1991; 146(4):1155-62.
81. Parker CE, Daenke S, Nightingale S, Bangham CR. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188(2):628-36.
82. Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, et al. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol 1992; 66(5):2928-33.
83. Koenig S, Woods RM, Brewah YA, Newell AJ, Jones GM, Boone E, et al. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol 1993; 151(7):3874-83.
84. Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med 1993; 177(6):1567-73
85. Bieganowska K, Hollsberg P, Buckle GJ, Lim DG, Greten TF, Schneck J, et al. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol 1999; 162(3):1765-71.
86. Johnson-Nauroth JM, Graber J, Yao K, Jacobson S, Calabresi PA. Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells. J Neuroimmunol 2006; 176(1-2):115-24.
87. Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLVI-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 2001; 183(2):197-205.
88. Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, et al. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95(4):1386-92.
89. Nowak MA, Bangham CR. Population dynamics of immune responses to persistent viruses. Science 1996; 272(5258):74-9
90. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 1999; 96(7):3848-53.
91. Asquith B, Mosley AJ, Barfield A, marshall SE, Heaps A, Goon P, et al. A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol 2005; 86(Pt 5):1515-23.
92. Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995; 37(2):167-5.
93. Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC Jr, Hasty KA, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002; 8(5):509-13.
94. Masuko K, Kato T, Ikeda Y, Okubo M, Mizushima Y, Nishioka K, et al. Dynamic changes of accumulated T cell clonotypes during antigenic stimulation in vivo and in vitro. Int Immunol 1994; 6(12):1959-66.
95. Batliwalla F, Monteiro J, Serrano D, Gregersen PK. Oligoclonality of CD8+ T cells in health and disease: aging, infection, or immune regulation? Hum Immunol 1996; 48(1-2):68-76.
96. Furukawa K, Mori M, Ohta N, Ikeda H, Shida H, Furukawa K, et al. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. J Clin Invest 1994; 94(5):1830-9.
97. Hara H, Morita M, Iwaki T, Hatae T, Itoyama Y, Kitamoto T, et al. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med 1994; 180(3):831-9.
98. Utz U, Banks D, Jacobson S, Biddison WE. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J Virol 1996; 70(2):843-51.
99. Hoger TA, Jacobson S, Kawanishi T, Kato T, Nishioka K, Yamamoto K. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. J Immunol 1997; 159(4):2042-8.
100. Eiraku N, Hingorani R, Ijichi S, Machigashira K, Gregersen PK, Monteiro J, et al. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. J Immunol 1998; 161(12):6674-80.
101. Ureta-Vidal A, Pique C, Garcia Z, Dehee A, Tortevoye P, Desire N, et al. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers. J Infect Dis 2001; 183(6):857-64.
102. Saito M, Nose H, Usuku K, Sabouri AH, Matsuzaki T, Izumo S, et al. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 2006; 246(1-2):37-43.
103. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17(3):138-46.
104. Horiuchi I, Kawano Y, Yamasaki K, Minohara M, Furue M, Taniwaki T, et al. Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis. J Neurol Sci 2000; 172(1):17-24.
105. Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alcantara L, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001; 23(9):503-7.
106. Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP, Bangham CR. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 2002; 99(9):3335-41.
107. Daenke S, Nightingale S, Cruickshank JK, Bangham CR. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol 1990; 64(3):1278-82.
108. Mahieux R, De The G, Gessain A. The tax mutation at nucleotide 7959 of human T-cell leukemia virus type 1 (HTLV-1) is not associated with tropical spastic paraparesis/HTLV-1-associated myelopathy but is linked to the cosmopolitan molecular genotype.J Virol 1995; 69(9):5925-7.
109. Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2000; 182(5):1343-9.
110. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection J Immunol 2000; 165(12):7278-84.
111. Yashiki S, Fujiyoshi T, Arima N, Osame M, Yoshinaga M, Nagata Y, et al. HLA-A*26, HLA-B*4002, HLAB* 4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses 2001; 17(11):1047-61.
112. Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, Forughipour M, et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 2005; 86(Pt 3):773-81.
113. Sonoda S, Fujiyoshi T, Yashiki S. Immunogenetics of HTLV-I/II and associated diseases J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(Suppl 1):S119-23.
114. Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, et al. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2002; 186(7):932-9.
115. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51(6):605-12.
116. Nishimura M, Maeda M, Matsuoka M, Mine H, Saji H, Matsui M, et al. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum Immunol 2000; 61(12):1262-9.
117. Seki N, Yamaguchi K, Yamada A, Kamizono S, Sugita S, Taguchi C, et al. Polymorphism of the 5'-flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis. J Infect Dis 1999; 180(3):880-3.
118. Tsukasaki K, Miller CW, Kubota T, Takeuchi S, Fujimoto T, Ikeda S, et al. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res 2001; 61(9):3770-4.
119. Sabouri AH, Saito M, Lloyd AL, Vine AM, Witkover AW, Furukawa Y, et al. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2004; 190(7):1279-85.
120. Rafatpanah H, Pravica V, Farid R, Abbaszadegan MR, Tabatabaei A, Goharjoo A, et al. Association of a novel single nucleotide polymorphism in the human perforin gene with the outcome of HTLV-I infection in patients from northeast Iran (Mashhad). Human Immnuol 2004; 65(8):839-46.
121. Saito M, Eiraku N, Usuku K, Nobuhara Y, Matsumoto W, Kodama D, et al. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals. J Neurol Sci 2005; 232(1-2):29-35.
122. Kodama D, Saito M, Matsumoto W, Sabouri AH, Izumo S, Arimura K, et al. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neuroimmunol 2004; 156(1-2):188-94.
123. Nobuhara Y, Usuku K, Saito M, Izumo S, Arimura K, Bangham CR, et al. Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease. Immunogenetics 2006; 57(12):944-52.
124. Bangham CR, Osame M. Cellular immune response to HTLV-1. Oncogene 2005; 24(39):6035-46.